3.2 ML aripiprazole 300 MG/ML Prefilled Syringe
- RxCUI
- 2636645
- RxNorm name
- 3.2 ML aripiprazole 300 MG/ML Prefilled Syringe
- Display name
- 3.2 ML aripiprazole 300 MG/ML Prefilled Syringe
- Full name
- 3.2 ML aripiprazole 300 MG/ML Prefilled Syringe
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Abilify Asimtufii | ARIPIPRAZOLE | Otsuka America Pharmaceutical, Inc | da4c07fd-1130-4341-bb44-63acfa4162be | 2025-04-04 | Boxed warning, Warnings, Adverse reactions | 2636645 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| da4c07fd-1130-4341-bb44-63acfa4162be | ARIPiprazole 960 MG in 3.2 ML Extended Release Prefilled Syringe [PSN] · 3.2 ML aripiprazole 300 MG/ML Prefilled Syringe [SCD] · aripiprazole 960 MG per 3.2 ML extended release Prefilled Syringe [SY] | 3 | 6 | These highlights do not include all the information needed to use ABILIFY ASIMTUFII safely and effectively. See full prescribing information for ABILIFY ASIMTUFII. ABILIFY ASIMTUFII ® (aripiprazole) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2002 | 20250404 |